Having trouble viewing this email? View in your browser.
ESCMID Logo

7 July 2020
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 

ECCVID Abstract Submission Opening Soon!

Don’t miss the opportunity to submit your abstract for the ESCMID Conference on Coronavirus Disease, taking place online from 23 – 25 September 2020.

The call will open on the 20th July 2020 and run for 2 weeks, closing on 3 August 2020.

See the ESCMID Website for the abstract submission guidelines and template.

› Read more

Public consultation phase open for
three new guidance documents

The following three guidance documents have now entered the Public Consultation Phase:

The ESCMID members wishing to comment on either of the three manuscripts should write to guidancedocuments[at]escmid.org indicating their ESCMID membership number in order to receive the confidential draft of the manuscript, along with the comments form for listing feedback:

1) Impact of COVID-19 on patients with liver disease: updated review of the EASL-ESCMID position paper
(deadline 12th July 2020)

2) Global guideline for the diagnosis and management of rare mold infections: An initiative of the ECMM in cooperation with ISHAM and TBD
(deadline 26th July 2020)

3) Global guideline for the diagnosis and management of the Endemic Mycoses: An initiative of the ECMM in cooperation with ISHAM and TBD
(deadline 26th July 2020)

For more information,
please visit the ESCMID website.

› Read more

Microbial Pathogenesis in Alzheimer’s Disease: research grants from IDSA

In order to identify a potential microbial link to Alzheimer’s disease, IDSA is offering up to ten (10), $100,000 research grants. All application submissions must be narrowly focused on elucidating the possible roles of infectious agents in the causation of Alzheimer’s disease. The awards will support innovative research including basic, clinical, and/or non-traditional approaches. International applications are welcome and you do not need to be a member of IDSA to apply!

› Read more
 

COVID-19 and One Health – Wednesday 8 July, 20:00 CEST

Join an international faculty for the upcoming live online websymposium event 'COVID-19 and One Health: can we do better?', being hosted by the Federation of European Academies of Medicine and the Federation of Veterinarians of Europe.

ESCMID Emerging Infections Task Force (EITaF) Chairperson Eskild Petersen will join the conversation addressing SARS-CoV-2 as a zoonosis: the human health perspective.

The Websymposium will take place on Wednesday, 8 July at 11:00 – 12:30 CEST.

View the Programme flyer here.

› Read more
 

GARDP Websymposium: Antimicrobial R&D in low- and middle-income countries

Don’t miss the next GARDP Websymposium, taking place on Thursday, 9 July at 09:00-10:30 CEST.

Join speakers Anand Anandkumar and Kamini Walia as they discuss the challenges facing, and opportunities arising for antimicrobial R&D in India.

Register on the GARDP Website. 

› Read more
 

Gilead COVID-19 Research Grant opportunity

Gilead has announced COMMIT™ (COvid-19 unMet MedIcal needs and associated research exTension) COVID-19 RFP program.

The COMMIT™ program will support well defined individual projects of no more than $250,000 USD or equivalent sum; projects that are more than $250,000 will require approval by Gilead prior to submission.

The full description of the program and the required forms can be found on the Gilead ISR website, here.

› Read more
 

CMI highlight: Childhood COVID-19: a multi-center retrospective study

Children are a special group with immature immune systems and respiratory systems, which make disease process and manifestation different from adults. This is also seen in the COVID-19 pandemic that has become prevalent all over the world, causing widespread concern. Chen et al. analysed the clinical data of 32 confirmed paediatric patients from 7 hospitals in Zhejiang province of eastern China to summarise clinical experiences in the diagnosis and treatment of paediatric COVID-19.

Early clinical investigations suggest that COVID-19 is predominantly prevalent in adults, with only a small percentage of paediatric patients, however the number of paediatric patients being reported is growing. The authors found that the majority of paediatric patients had at least one family members being a confirmed COVID-19 patient. Overall most of the children had mild symptoms with a good prognosis. However, viral RNA duration was much longer than clinical symptoms, specifically gastrointestinal samples had a very long duration. The authors conclude that while prognosis is generally better, more attention should be paid to household contact history investigation in the diagnosis of COVID-19 in young children.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.